Zenas BioPharma, Inc. Current Assets
Zenas BioPharma, Inc. (ZBIO) had Current Assets of $653.79 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $653.79M.
- 2026-03-31: Assets, Current $730.16M.
- 2025-12-31: Assets, Current $351.17M.
- 2025-09-30: Assets, Current $296.64M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $653.79M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $730.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $351.17M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $296.64M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $278.60M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $317.81M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $355.92M 10-K · filed 2026-03-16 |
| 2024-09-30 | $393.78M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $59.80M 10-K · filed 2025-03-11 |